Arkana Therapeutics

Private

Boulder, ColoradoHealthcare & Life Scienceshttps://arkanatx.com/

Last Round

Pre Seed

Jun 29, 2026

Total Funding Raised

$1.03M

Company Overview

Arkana Therapeutics is a biotechnology company that discovers and develops metabolite-based therapeutics for obesity.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share, Government Contracts

AI Layer

Non-AI

Keywords

targeted protein degradationlight-activated platformParkinson's diseaseprotein degraderneurodegenerative diseasephotopharmacologyalpha-synucleinsynucleinopathiesdrug discovery platformlight-inducible degraderdrug discoveryprecision medicinebiotechnology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Arkana Therapeutics Comps

Public and private peers based on sector, stage, and business model.

Arkana Therapeutics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Arkana Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Pre Seed	Jun 29, 2026
Grant	Apr 22, 2026
Grant	Oct 27, 2025

View all Funding Rounds

Key People

Founding team and executive leadership

Jack Gugel

CEO & Co-Founder

Founding Team

Arkana Therapeutics Investors

Notable investors and investment history

Arkana Therapeutics investors
Investor	Rounds
Venture Partners at CU Boulder	Grant
Buff Gold Ventures	Grant
OEDIT Advanced Industries Program	Grant

View all Investors

Arkana Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Arkana Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Arkana Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoulder, Colorado

Employee Range4

Year Founded2025

Last FundingJun 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.